Filing Flows

Filing Flows › Fresenius Medical Care AG (FMS) › Q1 2025

Fresenius Medical Care AG (FMS) Q1 2025 earnings results (first quarter 2025)

6-K filed May 6, 2025

Fresenius Medical Care AG (FMS) reported revenue of $4.9B for the first quarter 2025 (Q1 2025), +3% from a year earlier and -4% from the quarter before. Operating margin was 6.8%, net earnings $151M (3.1% of revenue).

Revenue$4.9B
Year over year+3%
Quarter over quarter-4%
Operating margin6.8%
Net earnings$151M

Fresenius Medical Care AG, Q1 2025: revenue $4.9B (+3% year over year), operating margin 6.8%, net earnings $151M, operating cash flow $163M. The chart follows the revenue to costs, profit and cash.

Q1 2025AmountQ/QY/Y
Revenue$4.9B-4%+3%
Operating profit$331M+28%+35%
Net earnings$151M+126%+113%
Operating cash flow$163M—+28%
Free cash flow$17.1M——

What changed

Revenue was €4.9B in Q1 2025, up 3% year over year and down 4% from the previous quarter. Health care services was the largest line at 77% of revenue. Health care products added €0.13B year over year (up 13%), 80% of the total change.

Operating profit was €0.33B, a 6.8% margin (up 1.6 points year over year). Of the extra revenue versus a year earlier, 54% reached operating profit, above the 5% margin then. Total costs grew 2% against revenue growth of 3%. Net earnings were €0.15B, up 113% year over year. The effective tax rate was 24.4%.

Operating cash flow was €0.16B (up 28% year over year), 86% of net income including minority interests. Working capital and other items used €0.03B. Capital expenditures of €0.15B left free cash flow of €0.02B.

Questions

What was Fresenius Medical Care AG's revenue in the first quarter 2025?

Fresenius Medical Care AG (FMS) reported revenue of $4.9B for the first quarter 2025 (Q1 2025), +3% from a year earlier and -4% from the quarter before.

Was Fresenius Medical Care AG profitable in the first quarter 2025?

Operating profit was $331M (6.8% of revenue) and net earnings $151M.

Open the interactive Sankey →

Source: Fresenius Medical Care AG 6-K on SEC EDGAR.